Details
Stereochemistry | UNKNOWN |
Molecular Formula | C15H13N3O3S |
Molecular Weight | 315.347 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)NC1=NC2=CC=C(C=C2N1)[S+]([O-])C3=CC=CC=C3
InChI
InChIKey=BEZZFPOZAYTVHN-UHFFFAOYSA-N
InChI=1S/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)
Molecular Formula | C15H13N3O3S |
Molecular Weight | 315.347 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:45 UTC 2023
by
admin
on
Fri Dec 15 15:16:45 UTC 2023
|
Record UNII |
OMP2H17F9E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 556.495
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
CFR |
21 CFR 520.1631
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
CFR |
21 CFR 520.1628
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
597217
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
CFR |
21 CFR 520.1629
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
WHO-VATC |
QP52AC02
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
CFR |
21 CFR 520.1630
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
435514
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
||
|
WHO-VATC |
QP52AC52
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
40854
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
32634
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000083039
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
758943
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
3853
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
Oxfendazole
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
DTXSID9044112
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
53716-50-0
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
OMP2H17F9E
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
m8304
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
C011030
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
C75229
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
OMP2H17F9E
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
1483301
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL42442
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
258-714-5
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
DB11446
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY | |||
|
SUB09519MIG
Created by
admin on Fri Dec 15 15:16:45 UTC 2023 , Edited by admin on Fri Dec 15 15:16:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
from Standard solution 1(Dissolve a quantity of USP Oxfendazole RS in Diluent to obtain a solution having a concentration of 0.1 mg per mL)
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
from Standard solution 2 (Dissolve a quantity of USP Fenbendazole RS in Diluent to obtain a solution having a concentration of 0.05 mg per mL)
CHROMATOGRAPHIC PURITY (TLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |